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Abstract
Background: The maintenance of the intestinal epithelium is of great importance for the survival of the organism. A
possible nervous control of epithelial cell renewal was studied in rats and mice.
Methods: Mucosal afferent nerves were stimulated by exposing the intestinal mucosa to capsaicin (1.6 mM), which
stimulates intestinal external axons. Epithelial cell renewal was investigated in the jejunum by measuring intestinal
thymidine kinase (TK) activity, intestinal
3H-thymidine incorporation into DNA, and the number of crypt cells labeled with
BrdU. The influence of the external gut innervation was minimized by severing the periarterial nerves.
Principal Findings: Luminal capsaicin increased all the studied variables, an effect nervously mediated to judge from
inhibitory effects on TK activity or
3H-thymidine incorporation into DNA by exposing the mucosa to lidocaine (a local
anesthetic) or by giving four different neurotransmitter receptor antagonists i.v. (muscarinic, nicotinic, neurokinin1 (NK1) or
calcitonin gene related peptide (CGRP) receptors). After degeneration of the intestinal external nerves capsaicin did not
increase TK activity, suggesting the involvement of an axon reflex. Intra-arterial infusion of Substance P (SP) or CGRP
increased intestinal TK activity, a response abolished by muscarinic receptor blockade. Immunohistochemistry suggested
presence of M3 and M5 muscarinic receptors on the intestinal stem/progenitor cells. We propose that the stem/progenitor
cells are controlled by cholinergic nerves, which, in turn, are influenced by mucosal afferent neuron(s) releasing
acetylcholine and/or SP and/or CGRP. In mice lacking the capsaicin receptor, thymidine incorporation into DNA and number
of crypt cells labeled with BrdU was lower than in wild type animals suggesting that nerves are important also in the
absence of luminal capsaicin, a conclusion also supported by the observation that atropine lowered thymidine
incorporation into DNA by 60% in control rat segments.
Conclusion: Enteric nerves are of importance in maintaining the intestinal epithelial barrier.
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Introduction
The intestinal epithelium consists of a single layer of columnar
cells about 25 mm high. It represents an outer surface of the
organism exposed to luminal contents of widely varying
composition. The epithelium is of great importance for the
survival of the organism, since chemicals and/or microorgan-
isms, if allowed to pass the epithelial barrier, may represent a
deadly threat. Thus, the intestinal epithelium may be looked
upon as being an important part of innate immunity. The
maintenance of the epithelium is secured by a rapid renewal, the
epithelium being replaced every 3–5 days in mammals [1]. The
key cells in this event are the intestinal stem and progenitor cells
located in the intestinal crypts. The present study describes
animal experiments, which suggestt h a tt h e r ei san e r v o u sr e f l e x
control of the stem/progenitor cells and, hence, rate of epithelial
cell renewal.
The nervous control of the gastrointestinal tract is exerted by
two systems: the extrinsic, efferent sympathetic and parasympa-
thetic nerves and the intrinsic enteric nervous system (ENS). The
latter represents a nervous system in the gastrointestinal tract,
controlling epithelial transport, motility and blood flow [2]. ENS is
composed of two major nerve plexuses, the myenteric and the
submucosal and of their interconnections. Most of the neurons of
the ENS are confined to the gastrointestinal wall, but extrinsic
nerves are also found in the ENS. Two major types of nervous
reflexes can be identified in the ENS: intramural reflexes and axon
reflexes. Intramural reflexes are confined to the intestinal wall.
The peristaltic reflex is an example of an intramural reflex initiated
by luminal distension [2]. Branching external afferent nerves
constitute the morphological bases of axon reflexes.
Most investigations of the nervous control of gastrointestinal
functions have been concerned with its control of motility, blood
flow or epithelial transport. Although the extrinsic control of
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16295epithelial cell proliferation usually is discussed in terms of growth
factors, peptide hormones and inflammatory mediators (for
review, see reference [3]), there are observations to suggest also
a nervous control of intestinal cell renewal. In most of these studies
the influence of the extrinsic nerves has been investigated,
suggesting that both branches of the extrinsic innervation may
increase mitotic rate in the crypt cells [4–6]. Chemical ablation of
the myenteric plexus leads to an increased crypt cell proliferation
both in the small intestine [6–8] and in the colon [9,10], indicating
that myenteric nerves may exert an inhibitory influence on
intestinal cell renewal.
We have earlier demonstrated that ENS plays an important role
in the control of fluid transport. In fact, in many, if not most, types
of acute diarrhea, an activation of ENS is the major mechanism
underlying the observed intestinal fluid loss [11–13]. Diarrhea can
be looked upon as being an innate immunity response, since the
secreted fluid dilutes the potentially noxious agent(s). The
maintenance of the epithelial barrier is also important for innate
immunity. Therefore, we decided to investigate if intestinal
contents, via the ENS, also may influence epithelial cell renewal.
Most experiments were performed on intestinal segments that had
been acutely denervated by cutting the nerves accompanying the
superior mesenteric artery, minimizing the influence of the
external innervation. The ENS was activated in two different
ways: In one type of experiments an intramural secretory reflex
was stimulated by exposing the intestinal mucosa to cholera toxin
[11]. In another series we utilized capsaicin, the ‘‘hot’’ agent of red
pepper, to activate thin mucosal afferents [14]. Capsaicin is known
to activate the TRPV1 receptor. Cell renewal was studied in three
different ways: We determined deoxythymidine kinase (TK)
activity in the intestinal wall. TK facilitates the phosphorylation
of deoxythymidine, associated with the formation of DNA [15].
We also measured the rate of incorporation of radioactively
labeled thymidine into intestinal DNA. Finally, epithelial cell
renewal was estimated by means of bromodeoxyuridine (BrdU), a
thymidine analogue possible to localize at the cellular level in
tissue sections with immunohistochemistry.
Results
Rapid cell renewal in the intestine is located to the crypts
TK activity and methyl-
3H-thymidine incorporation into DNA
was measured in the whole intestine. Hence, it was important to
ensure that the recorded activity/incorporation mainly reflected
events in the intestinal crypt stem/progenitor cells. This was tested
in two ways. First, the left panel of Figure 1 shows an
autoradiograph of the small intestine from a rat given methyl-
3H-
thymidine i.v. 6 h prior to the removal of the intestine. Dark field
microscopy shows that the labeled thymidine was mainly located to
the crypts, where intestinal epithelial stem/progenitor cells are
found [16–18]. The right panel shows the same histological section
in regular light microscopy. Figure 2 illustrates the localization of
labeled thymidine at a higher magnification in intestinal crypts. The
photographic grains are only seen above the nuclei of the cells
(indicated by arrows). Second, in another type of experiments BrdU
(a thymidine analogue) was given i.v. (50 mg kg
21). Two h after the
i.v. injection, BrdU immunoreactivity was exclusively found in the
crypt epithelial cells (Figure 3).
Cholera toxin does not increase rate of epithelial renewal
Cholera toxin evokes an intestinal fluid secretion mainly by
stimulating nervous reflex(es) contained within the ENS [11,13].
Figure 1. Autoradiography of rat small intestine after giving tritiated thymidine i.v. The labeled compound (50 mCi
3H-methyl-thymidine)
was administred 6 h prior to removing the intestine The left panel illustrates dark field microscopy of an autoradiogram showing radiolabeled cells
(white spots) almost exclusively located in the epithelial layer of the crypts of Lieberku ¨hn. To the right the same section is seen in light microscopy.
Van Gieson.
doi:10.1371/journal.pone.0016295.g001
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three hours did not influence TK activity (91.2611.2% (mean 6
s.e.m) of control; n=5; p=0.5), but decreased the incorporation of
labeled thymidine into DNA (84.465.5% of control; n=5;
p,0.05).We conclude that in the present short term experiments
nervous reflexes activated by cholera toxin do not increase rate of
epithelial renewal.
Luminal capsaicin increases rate of epithelial renewal
Two experimental protocols were used in the capsaicin
experiments, ‘‘non-perfusion experiments’’ and ‘‘perfusion exper-
iments’’ (see Methods). Since both techniques indicated that a
1.6 mM capsaicin solution evoked a consistent increase of TK
activity (152.768.6% of TK activity in control segments (non-
perfusion experiments; n=7; p-value ,0.05) and 149.8614.4% of
control segments (perfusion experiments; n=6; p-value ,0.05;
Figure 4), this concentration was used in subsequent experiments,
most of which were performed with the perfusion technique.
TheincorporationoflabeledthymidineintoDNAwassignificantly
increased after 2 h capsaicin perfusion (178.0630.1% of incorpora-
tion in control segments; n=6; p,0.05). Furthermore, the number of
BrdU labeled crypt cells increased concomitantly in the capsaicin
group as shown on left part of Figure 5, based on counting labeled
cells in 255 crypts in control and 249 crypts in capsaicin segments
(control segments: 15.060.3 labeled cells/crypt; capsaicin segments:
17.960.3 labeled cells/crypt; n=5; p,0.01). Hence, exposing the
intestinal mucosato 1.6 mM capsaicin increased TK activity and
3H-
thymidine incorporation into DNA reflecting events in crypt
epithelial cells as confirmed by the BrdU experiments.
The capsaicin effect on epithelial renewal is mediated by
nerves
Capsaicin was used to activate selectively thin afferent nerve
fibers presumably via the vallinoid receptor 1 (TRPV1) [14]. We
explored if capsaicin indeed activated afferent nerves by
monitoring changes of heart rate on line after luminal adminis-
tration of a 1.6 mM capsaicin. The periarterial nerves were not
severed in these experiments. Within ten minutes 1.6 mM
capsaicin heart rate increased by 46.268.2 min
21, whereas heart
rate was not affected (24.765.1 min
21) in control experiments
(n=6; p,0.05), suggesting that luminal capsaicin activates
nervous afferents.
In one series of experiments the extrinsic intestinal nerves were
allowed to degenerate for 2–3 weeks after cutting the nerves
around the superior mesenteric artery. The success of the
denervation procedure was tested by immunohistochemical
determinations of tyrosine hydroxylase in the intestine, located
to extrinsic adrenergic nerve fibers [19]. Absence of labeled nerve
fibers was taken to indicate a successful denervation. Exposing
such ‘‘chronically’’ denervated intestinal segments to capsaicin did
not significantly increase TK activity (102.763.1% of control;
n=5). This is significantly lower than the capsaicin effect observed
in ‘‘acutely’’ denervated segments (144.168.3%; n=18; p,0.01).
To further investigate the possible involvement of nerves in the
capsaicin response, the intestinal mucosa was anesthetized with
lidocaine (see Methods). In these experiments (Figure 6) no
significant increase of TK activity was recorded (perfusion
experiments: TK activity in capsaicin segments 97.5614.4% of
control; n=8; p=0.58; non-perfusion experiments: TK activity in
capsaicin segments 103.1613.7% of control; n=7; p=0.74),
indicating a nervous involvement in the capsaicin response.
Figure 2. The distribution of
3H-methyl-thymidine in an
intestinal crypt (C) as shown by autoradiography. The labeled
compound (50 mCi
3H-methyl-thymidine) was administred 6 h prior to
removing the intestine. Only cell nuclei were found to be labeled
(arrows).
doi:10.1371/journal.pone.0016295.g002
Figure 3. BrdU labeling of the small intestine after i.v.
administration. BrdU (50 mg/kg b.wt.), a thymidine analogue, was
given 2 h prior to removing the intestine. The dark labeling by BrdU is
exclusively located to the nuclei of intestinal crypt cells. Mayer’s
haematoxylin.
doi:10.1371/journal.pone.0016295.g003
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obtained in experiments with the TPRV1 receptor blocker
capsazepine (3 mg/kg i.v.) given prior to the intraluminal
administration of capsaicin. In these experiments the TK activity
of the capsaicin segment was 97.267.3% (n=7) of that measured
in corresponding control segments (p,0.01 compared to a value of
144.168.3 per cent in experiments without capsazepine; n=18).
Hence, the capsaicin effect on TK activity was mediated by a
TPRV1 receptor. Since the TPRV1 receptor is known to be
located on many extrinsic afferent axons[14], the results support
the proposal that the capsaicin effect involves nerves.
Finally, hexamethonium (a cholinergic, nicotinic receptor
blocker; 10 mg/kg b.wt.; n=8) significantly attenuated the effect
of capsaicin on TK activity measuring 96.5610.7% of the activity
in capsaicin free segments (p,0.01 compared to 144.168.3 per
cent in experiments without hexamethonium; n=18). These
results suggest that the capsaicin effect was mediated by ENS
reflex(es) containing at least one cholinergic synapse.
The capsaicin effect on epithelial renewal is mediated by
muscarinic and peptidergic receptors
The experiments with chronically denervated intestines de-
scribed above suggested that capsaicin stimulates an axon reflex.
In many organs calcitonin gene related polypeptide (CGRP) or
Figure 4. The effect on intestinal thymidine kinase activity of
exposing the intestinal mucosa to capsaicin (0.16 or 1.6 mM).
Thymidine kinase activity is expressed in per cent of activity measured
in control segments (no capsaicin). The experiments were performed
using two types of preparations. In most experiments only the proximal
ends of the segments were cannulated with plastic tubing and the
intestinal segment was perfused by means of a pump at a rate of 20 mL
per min (‘‘perfusion experiments’’; n=6). In other experiments the distal
ends were also provided with plastic tubing closed by plugs (‘‘non-
perfusion experiments’’; n=7). Asterisks indicate statistical significance.
Mean 6 s.e.m.
doi:10.1371/journal.pone.0016295.g004
Figure 5. Rat: BrdU labeled cells per crypt in intestinal
segments exposed to a capsaicin or a control solution. BrdU
(50 mg/kg bwt) was given i.v. 2 h prior to removal of the intestinal
segments. The number of labeled cells in 255 crypts in control (n=5)
and in 249 crypts in capsaicin segments (n=5) were counted. Asterisk
indicates statistical significance. Mean 6 s.e.m. Mouse: BrdU labeled
cells per crypt in wild type or capsaicin receptor knock-out
mice. Five capsaicin receptor knock-out mice (2/2; 225 crypts) and in
five wild type mice (WT; 215 crypts) were investigated. BrdU (100 mg/
kg b.wt.) was administered i.p. 2 h before removal of the small intestine.
Asterisk indicates statistical significance. Mean 6 s.e.m.
doi:10.1371/journal.pone.0016295.g005
Figure 6. The effect of capsaicin on intestinal thymidine kinase
activity after anesthetizing the mucosa with lidocaine. Thymi-
dine kinase activity is expressed in per cent of activity measured in
control segments (no capsaicin). Asterisks indicate statistical signifi-
cance between the two groups of experiments (perfusion experiments,
n=8; non-perfusion experiments, n=7). Mean 6 s.e.m.
doi:10.1371/journal.pone.0016295.g006
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[see e.g. references 20–22]. To elucidate if this also was the case in
the present experiments two types of studies were performed. First,
blocking the CGRP receptors (human 8–37 a-CGRP; 1 mg kg
21
b.wt. i.v.) or the SP receptors (more specifically the NK1 receptors:
Sendide; 1 mg kg
21 b.wt. i.v.) abolished the increase of TK
activity evoked by capsaicin (Figure 7; CGRP receptors: TK
activity in capsaicin segments 78.569.7% of control segments;
n=6; p,0.001 compared to control experiments; NK1 receptors:
TK activity in capsaicin segments 82.666.8% of TK activity in
control intestines; n=6; p,0.001 compared to control experi-
ments) and the augmented incorporation of
3H-thymidine into
DNA (Figure 8; CGRP receptors: incorporation in capsaicin
segments 68.9614% of control intestines; n=6; p,0.01; NK1
receptors: incorporation in capsaicin segments 90.669.8% of
control; n=6; p,0.001) induced by luminal capsaicin. The doses
used have been previously shown to block effects of CGRP and SP
[22–24]. Second, infusing the neurotransmitters retrogradely in
the carotid artery at rates of 10
29 mol per min for 1 h increased
significantly intestinal TK activity compared to activity at the start
of infusion (Figure 9; CGRP: TK activity 141.067.6% of activity
at time 0; n=5; p,0.05; SP: TK activity 143.9620.7% of activity
at time 0; n=5; p,0.05).
There are two major types of cholinergic receptors, nicotinic
and muscarinic. Above we described results from experiments with
hexamethonium, a nicotinic receptor blocker. To block the
muscarinic receptors, atropine (0.5 mg kg
21 b.wt.) was given i.v.
Atropine significantly diminished the intestinal TK response to
capsaicin (Figure 7; TK activity in capsaicin segments 91.865.6%
of control; n=6; p,0.001 compared to experiments without
atropine) and the capsaicin evoked increase of
3H-thymidine
incorporation into DNA (Figure 8; incorporation in capsaicin
intestines 70.9616.5% of control; n=6; p=0.002 compared to
experiments without atropine).
Figure 7. The effect of neurotransmitter receptor antagonists
on capsaicin evoked increase of thymidine kinase activity. The
receptor antagonists tested were: Sendide (NK1 receptor antagonist);
8–37 a-GGRP (CGRP receptor antagonist); atropine (muscarinic receptor
antagonist). Thymidine kinase activity is expressed in per cent of activity
measured in control segments (no capsaicin). N=6 for each antagonist
experiments. Asterisks indicate statistical significance compared to
control. Mean 6 s.e.m.
doi:10.1371/journal.pone.0016295.g007
Figure 8. The effect of neurotransmitter receptor antagonists
on capsaicin evoked increase of
3H-thymidine incorporation
into DNA. The receptor antagonists tested were: Sendide (NK1
receptor antagonist); 8–37 a-GGRP (CGRP receptor antagonist); atropine
(muscarinic receptor antagonist). The receptor blockers were given as
described in Methods.
3H-thymidine incorporation is expressed in per
cent of incorporation measured in control segments (no capsaicin).
Asterisks indicate statistical significance compared to control. Mean 6
s.e.m.
doi:10.1371/journal.pone.0016295.g008
Figure 9. Thymidine kinase activity in intestinal segments after
i.a. infusion of substance P or CGRP. The peptides were infused for
one hour at a rate of 1029 mol per minute with or without prior
administration of atropine (0.5 mg per kg b.wt. i.v.). Note that in these
experiments thymidine kinase activity is expressed in per cent of
activity measured in segments removed at time 0. Asterisks indicate
statistical significance. Mean 6 s.e.m.
doi:10.1371/journal.pone.0016295.g009
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effect of atropine on rate of
3H-thymidine incorporation into DNA
in control segments. After 2 h labeled nucleotide incorporation
into DNA was 1017681 DPM per mg DNA in animals not
receiving atropine and 380665 DPM per mg DNA in experiments
with atropine (n=6 in both groups; p,0.01 comparing the two
groups). Hence, atropine lowered incorporation to about 40% of
control suggesting an ongoing cholinergic, nervous influence in the
absence of luminal capsaicin.
A possible interaction between muscarinic and peptidergic
transmission was investigated by intravascular infusion of CGRP
or SP after atropine administration. No CGRP or SP effect on TK
activity could be demonstrated after giving atropine. (Figure 9;
CGRP: 90.867.1% of TK activity at start of peptide infusion;
n=7; p,0.05 compared to CGRP experiments without atropine;
SP: 73.865.7% of TK activity at time 0; n=7; p,0.05). The
simplest explanation for these observations is that CGRP and SP
influence cholinergic neuron(s), which, in turn, control the
intestinal stem cells.
To elucidate if muscarinic receptors were present on the
intestinal stem/progenitor cells, we performed immunofluores-
cence studies using antibodies against the five different muscarinic
receptors (M1–M5) described in the literature [25]. As on many
other effector cells innervated by cholinergic neurons, immuno-
reactivity for more than one type of muscarinic receptors (M3 and
M5) was identified in the intestinal crypts [25]. The left panel of
figure 10 illustrates the distribution of the immunoreactivity for the
M5 receptor in the crypts as revealed by confocal microscopy in a
4 mm thin section of a crypt wall. Hence, no crypt lumen is seen
and the crypt cells are cross-sectioned. The disclosed fluorescence
pattern is consistent with the immunoreactivy being located to cell
membranes. The round structure in the middle of the figure is in
all probability a cross-sectioned goblet cell surrounded by
immunoreactivity. Tissue sections exposed only to the secondary
antibody did not exhibit any fluorescence (Figure 10, right panel).
Cheng and Leblond [26] proposed that the so called base
columnar cells were the intestinal stem cells generating all types of
epithelial cells, a hypothesis recently supported by Barker et al.
[17,18]. Thus, the intestinal stem cells seem to be the slender cells
situated between the Paneth cells. We studied the possible
presence of muscarinic receptors on these cells. Two types of
muscarinic receptors M3 and M5, were investigated. Immunore-
activity to M3 and M5 receptors was identified on the presumed
stem cell membrane, as illustrated for the M3 receptor on the left
panel of Figure 11. The right panel shows the appearance of the
tissue when exposed only to the secondary antibody.
Rate of epithelial renewal is decreased in capsaicin
receptor knock-out mice
To investigate if the capsaicin receptor was of importance for
cell renewal during ‘‘normal’’ conditions, experiments were
performed on wild type mice and on mice lacking the TRPV1
gene [27].
3H-thymidine (2 mCi) or BrdU (100 mg/kg b.wt.) were
injected i.p. 2 h prior to extirpating the intestinal segments.
3H-
thymidine incorporation into DNA was 529646 DPM per mg
DNA (n=5) in control mice and 340672 DPM per mg DNA
(n=5) in TRPV1 knock out mice (p,0.05).
The BrdU labeled cells were exclusively found in the intestinal
crypts (cf. Figure 3). BrdU labeled cells in 215 crypts in wild type
mice and 225 crypts in TRPV1
2/2 mice were counted. The
number of labeled cells per crypt was significantly lower in
TRPV1
2/2 than in wild type mice (right part of Figure 5; wild
type: 11.460.2 BrdU labeled cells/crypt; knock-out: 9.260.2
BrdU labeled cells/crypt; n=5 in both groups; p,0.01). Thus, in
mice devoid of capsaicin receptors rate of
3H-thymidine
incorporation into DNA and number of BrdU labeled crypt cells
were significantly lower than in wild type mice.
Discussion
The intestinal epithelium is the most rapidly self-renewing
epithelium in adult mammals, being replaced every 3–5 day. Each
crypt contains 4–6 long-lived stem cells that are constantly
dividing. The daughter cells of the stem cells (here called
progenitor cells) divide every 12–16 h as they move ‘‘upwards’’
along the crypts generating some 300 cells per crypt every day
[28]. The present study provides evidence for a nervous control of
intestinal stem/progenitor cells in vivo. We have demonstrated that
luminal capsaicin (1.6 mM), stimulating thin nervous afferents,
increases intestinal TK activity,
3H-thymidine incorporation into
DNA and number of BrdU labeled crypt cells. No such effects
were evoked by cholera toxin. Several observations strongly
indicate that the observed capsaicin effects were nervously
mediated. Hence, lidocaine, a local anesthetic, and antagonists
to four different neurotransmitter receptors (muscarinic, nicotinic,
NK1 and CGRP receptors) significantly attenuated the capsaicin
response. A nervous involvement was also indicated by the failure
of capsaicin to influence TK activity after allowing a degeneration
Figure 10. The localization of M5 muscarinic receptor immunoreactivity in intestinal crypts. The picture is photographed by confocal
microscopy corresponding to a 4 mm thick section of the wall of the crypts. Hence, no crypt lumen is seen and the crypt cells are cross-sectioned. The
left panel of the figure suggests that the M5 receptor is located to the plasma membrane of the crypt cells. Tissue sections exposed only to the
secondary antibody did not exhibit any fluorescence (right panel).
doi:10.1371/journal.pone.0016295.g010
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capsaicin effect was mediated by TRPV1 receptors, known to be
located on extrinsic afferent nerves [20], the capsaicin effect being
abolished by the TRPV1 receptor blocker capsazepine.
In the present study the measured TK activity has been taken as
indicator of rate of cell renewal of the intestinal epithelium. The
reasons for this are the following: TK is an important enzyme in
DNA replication, phosphorylating the nucleoside before being
incorporated into DNA. The enzyme exists in a cytosolic and
mitochondrial form [15]. Cytosolic TK is present only in
proliferating cells. Its importance for cell renewal is suggested by
the observations that TK activity in the crypts is about 20 times
higher than in the villi when expressed per unit tissue weight or
DNA weight [29,30]. This conclusion is also supported by our
observations that
3H-thymidine or BrdU injected intravenously
was localized almost exclusively to the nuclei of crypt cells
(Figures 1, 2 and 3), as also shown by Lipkin [31] for labeled
thymidine. Furthermore, the increased incorporation of thymidine
into DNA and the increased number of BrdU labeled crypt cells in
response to luminal capsaicin strongly suggest that the augmented
TK activity reflected a change of cytosolic TK activity. Finally,
nerve transmitter receptor antagonists concomitantly abolished the
increase of TK activity and thymidine incorporation into DNA
(compare Figures 7 and 8).
It might be argued that the increase of total intestinal TK
activity reflects a proliferation of other cells than the stem/
progenitor cells of intestinal crypts. Observations reported in the
literature indicate that this is unlikely. Smooth muscle cells show
almost no renewal in the mouse stomach [32]. Fibroblasts in the
intestinal submucosa are renewed with turn over times varying
between 100 and 130 days [33]. Hence, the two most dominating
tissues of the intestinal wall, apart from the epithelium, show no
proliferation within the short time of the present experiments.
The ‘‘chronic denervation’’ experiments are key experiments in
the analysis of the anatomical arrangement of the nerves
influencing intestinal stem/progenitor cells, since such experi-
ments make it possible to elucidate if a studied reflex is confined to
the intestinal wall (‘‘intramural reflex’’) or mediated via an axon
reflex. An axon reflex may be influenced by severing an afferent
neuron, whereas an intramural reflex will not. Thus, the
periarterial nerves were cut and acute experiments were
performed 2–3 weeks later, when the extrinsic innervation
(afferent and efferent) had degenerated. The absence of extrinsic
nerves was confirmed by immunohistochemical investigations of
tyrosine hydroxylase, a rate limiting enzyme in catecholamine
synthesis [19]. In chronically denervated rats luminal capsaicin
failed to cause an increase of TK activity, indicating that capsaicin
exerted its effect via an axon reflex. These observations are
consistent with the TRPV1 receptors being present only on
extrinsic afferent nerves of the gut [20].
There exist a number of criteria for neurotransmitter
candidates to be accepted as true transmitters. Observations
reported in this and other studies indicate that most of these
criteria have been fulfilled with regard to SP and CGRP and the
afferent nervous control of intestinal cell renewal. First,
immunohistochemical investigations have revealed intestinal,
extrinsic, afferent, nerves containing SP and CGRP [14,20].
Second, subgroups of the capsaicin sensitive neurons show SP
and/or CGRP immunoreactivity [20]. Third, blocking the
receptors for NK1 and CGRP significantly attenuated the effect
of luminal capsaicin on TK activity and
3H-thymidine incorpo-
ration (Figures 7 and 8). Fourth, intra-arterial administration of
the two peptides significantly increased TK activity (Figure 9).
Fifth, a release of SP or CGRP from stimulated afferent neurons
has been reported in the literature [22,34–36]. Thus, taken
together the observations clearly suggest that SP and CGRP are
involved in the capsaicin effect on epithelial cell renewal. The
current results indicate, however, that the NK1 or CGRP
receptors are not localized to the stem/progenitor cells, since
atropine abolished the TK increase induced by intra-arterially
i n f u s e dS Po rC G R P( F i g u r e9 ) .
Capsaicin sensitivity is a trait of a subgroup of the unmyelinated
C fibres but includes also some of the thinly myelinated Ad fibres.
Capsaicin stimulated receptors (TRPV1) are localized to extrinsic,
afferent neurons usually considered to belong to the nociceptor
system, a set of nerves that can be activated by stimuli (mechanical,
thermal, chemical) capable of causing tissue damage. The TRPV1
receptor is located on free nerve endings of at least on two different
types of neurons, one being a heat sensitive neuron and the other
being a peptidergic, polymodal nociceptor neuron [37].
Figure 11. The localization of M3 muscarinic receptor immunoreactivity on intestinal stem cells. The stem cells, indicated by arrows, are
slender cells located between the Paneth cells (PC) at the very base of the crypts [17,26]. The left part of the figure indicates that the muscarinic
receptor M3 is located to the plasma membrane of the presumed intestinal stem cells. The tissue section in the right panel was only exposed to the
secondary antibody. Mayer’s haematoxylin. CL = crypt lumen.
doi:10.1371/journal.pone.0016295.g011
Nervous Control of Stem Cells
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e16295Combining observations reported in the literature with the
findings of the current investigation it is possible to propose a
model to explain the findings of the present study. The model is
shown on Figure 12 and the observations that constitute the basis
for the model are briefly summarized in Table 1. It should be
underlined that Figure 12 represents the simplest model that can
be constructed from our findings and the observations reported in
the literature. It is a working hypothesis, which can be used when
designing further experiments to prove or disprove the proposed
model. The synapse between the afferent neuron and the
cholinergic neuron has been located to the submucosal plexus
in the figure for two reasons: first, most neurons controlling
mucosal functions have their cell somas in the submucosal plexus.
Second, luminal capsaicin transiently reduces CGRP-like immu-
noreactivity in the submucosal but not in the myenteric plexus
[39].
The proposed axon reflex control of intestinal cell renewal, may,
however, not be the only nervous control of intestinal stem cells.
We observed that atropine administration markedly attenuated
nucleotide incorporation into DNA also in control segments. A
rough calculation based on the averages of nucleotide incorpora-
tion (DPM per mg DNA) indicates that atropine decreased
incorporation to about 40% of control. Hence, other enteric
nerves than the thin extrinsic mucosal afferents may influence stem
cell/progenitor cell proliferation, the cholinergic neuron being the
final common pathway for more than one reflex. In fact, the
results indicate that nervously released acetylcholine may play a
very important role in the stem cell niche of the small intestine.
With regard to the type of epithelial cells controlled by enteric
nerves, observations reported by Bjerknes and Cheng [40,41]
indicate that the enteric nerves control the proliferation of the
columnar daughter cells.
There is a fairly extensive literature dealing with muscarinic
receptors and cell proliferation, in normal or cancerous cells (for
reviews see [42,43]). The muscarinic influence on proliferation is,
at least in part, mediated by the ‘‘classical’’ signalling pathways for
muscarinic receptors, the inositol-phospholipid signalling cascade
[42] involving two second messengers, diacylglycerol and inositol
1,4,5-trisphosphate (IP3). This pathway is, however, not the only
one mediating the muscarinic effect. Several studies report that the
muscarinic receptor also is coupled to the mitogen-activated
protein kinase (MAPK) pathway probably via a transactivation of
Table 1. Observations supporting the model of Figure 12.
Capsaicin stimulates intestinal extrinsic but not intrinsic afferent nerves [14,19]
A subset of capsaicin sensitive nerves releases SP and/or CGRP upon stimulation
[14,22,38]
ChAT and CGRP immunoreactivity is co-localized in afferent, small diameter
neurons [38]
The capsaicin effect on intestinal stem/progenitor cells is mediated by an axon
reflex (TS)
Most axon reflexes in different organs mediate their effects by SP and/or CGRP
[20,21,22]
The capsaicin effect on cell renewal is blocked by nicotinic, SP and CGRP
antagonists (TS)
SP and CGRP stimulate intestinal cell renewal (TS)
The effect of SP and CGRP on cell renewal is mediated by cholinergic receptors (TS)
There are cholinergic receptors on intestinal stem/progenitor cells (TS)
TS: this study.
doi:10.1371/journal.pone.0016295.t001
Figure 12. Model of axon reflex control of cell renewal in the small intestine. The model is in part based on the findings of the present
study (cf. Table 1) and is consistent with known types of neurons in the intestinal wall. It implies that the direct control of the stem/progenitor cells is
exerted by a cholinergic neuron, which, in turn, is under the influence of an axon reflex releasing CGRP/SP/acetylcholine. Ach: acetylcholine; CGRP:
calcitonin gene related peptide; SP: substance P; CNS: central nervous system.
doi:10.1371/journal.pone.0016295.g012
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the basolateral membrane of the crypt cell epithelium [48].
Besides luminal capsaicin we investigated the effect of cholera
toxin on TK activity and thymidine incorporation into DNA. It
was observed that the toxin, if anything, decreased cell renewal to
judge by attenuated nucleotide incorporation into DNA. This is
consistent with earlier observations that the final neurotransmitter
in the secretory reflex activated by cholera toxin is not
acetylcholine but vasoactive intestinal polypeptide (VIP) [49–52].
Atropine does not attenuate cholera secretion [13] excluding a
muscarinic mechanism. Furthermore, in contrast to the present
findings chronic denervation does not influence the secretory
response to cholera toxin [53]. We conclude that cholera toxin and
capsaicin stimulate two different reflexes with different final
neurotransmitters, one being confined to the intestinal wall
(cholera toxin reflex), releasing VIP, and the other being an axon
reflex (capsaicin reflex) releasing acetylcholine at the effector cell.
We have earlier reported that ENS is of great importance in
explaining fluid secretion in acute diarrhoea [11–13]. As pointed
out in the introduction diarrhoea can be looked upon as being an
innate immunity response, since the secreted fluid dilutes the
noxious agent(s). Furthermore, fluid secretion is often accompa-
nied by a nervously induced motility response propelling the
intestinal contents aborally [54]. Capsaicin activated intestinal
nerves evoke an intestinal vasodilatation [22] and may be involved
in the control of mucus secretion [55] and intestinal homing of
leukocytes [56]. Taken together with the present observations it
suggests that ENS coordinates several innate immunity mecha-
nisms in the gut.
As discussed above the capsaicin receptor TPRV1 is usually
considered to be a nociceptor sensing potentially noxious stimuli.
It may, however, also participate in physiological mechanisms.
The contents of the intestinal lumen influences mucosal morphol-
ogy, parenteral feeding leading to a decreased mucosal thickness
[57]. This is usually explained in terms of trophic factors, such as
hormones. However, the studied reflex may be involved. There
are at least three physiological ways by which the intestinal
contents may influence mucosal afferent nerves. First, the TRPV1
receptor seems to be an osmoreceptor activated by hyperosmo-
lality [58]. A tissue hyperosmolality has been demonstrated in the
upper parts of intestinal villi in several species with different
techniques [59], measuring about 800 mOsm in humans and cats
provided the intestinal contents contain sodium and glucose. We
propose that TRPV1 receptors are activated by a villous tissue
hyperosmolality. Such a mechanism may explain the present
findings in the knock-out mice implying that the capsaicin receptor
is important for cell renewal even in the absence of luminal
capsaicin.
Second, intake of food leads to the presence of pancreatic
proteases in the intestinal lumen. It has been shown that
proteinase-activated receptors 1 and 2 (PAR-1, PAR-2) are
present on the apical border of enterocytes and activated by
trypsin [60,61]. In the case of PAR-2 receptors indirect evidence
supports the proposal that a stimulation of this receptor may
influence firing in afferent nerves from the gut. Thus, Cenac et al.
[62,63] and Nguyen et al. [64] reported that exposing the colonic
mucosa to a PAR-2 receptor agonist causes a neurogenic
inflammation via capsaicin sensitive nerves. Furthermore, the
PAR-2 induced inflammation was attenuated by NK1 and CGRP
antagonists.
Third, one may speculate that the intestinal contents via the
discharge of hormones from enteroendocrine cells activate
mucosal afferents to increase epithelial cell renewal. A similar
chain of events has been proposed for the activation of intramural
secretory nervous reflexes by e.g. cholera toxin [11,13] and
rotavirus [12]. The finding reported by Bjerknes and Cheng [65]
that glucagon-like-peptide-2 exerts its stimulatory effect on
epithelial proliferation via nerves may be explained by such a
mechanism.
Microorganisms in the intestinal lumen are obvious examples of
potential noxious agents. Their presence may be recorded by the
intestinal epithelium, functioning as a mucosal defence early
warning system. Using membrane-associated or intracellular
pattern-recognition molecules, such as toll-like receptors and
Nod proteins, the epithelial cells sense the microorganisms [66].
This, in turn, may evoke a release of cytokines, prostaglandins
and/or nitrous oxide from the enterocytes [67], biologically potent
compounds with receptors on capsaicin sensitive nervous den-
drites. Invading microorganisms may evoke an inflammatory
response. Many of the substances participating in an inflamma-
tion, such as cytokines, prostaglandins, adenosine, bradykinin,
histamine and 5-hydroxytryptamine, may directly or indirectly via
activation of immunocytes, stimulate the studied axon reflex
[38,68,69]. A morphological characteristic of ulcerative colitis is
the ‘‘reactive‘‘ hyperplasia of the epithelium [70]. One may
speculate this hyperplasia may, at least in part, reflect an
inflammatory activation of the axon reflex controlling intestinal
stem/progenitor cells. Similar mechanisms may exist in connec-
tion with inflammation of other mucosae, as in the air ways and
the urinary tract.
It is well established that there is a relationship between tissue
repair and cancer, implying that chronic tissue injury may lead to
malignancy (see e.g. [71]). A well-known example is colon cancer
developing in longstanding ulcerative colitis. It has been suggested
that overall risk of cancer development depends on the number of
activated stem cells. Any repeated stimulus leading to a chronic
increase in stem cell numbers could result in a higher overall
frequency of cancer formation [28,72]. Furthermore, it has been
pointed out that the efficiency of carcinogenesis in tumour models
is increased when combining mutagenic agents with agents that
induce cell proliferation [73]. In this context it is interesting to note
that Frucht and coworkers [74] found that 6 out of 10 human
colon cancer cell lines were provided with functional muscarinic
cholinergic receptors. Therefore, in view of the findings of the
present study, one may pose the question if long standing
activation of mucosal afferent nerve fibres by e.g. inflammation,
may, via a cholinergic stimulation of muscarinic receptors and
transactivation of EGF receptors, contribute to the development of
cancer by their influence on epithelial proliferation.
Methods
Ethical approval
The protocol used in the present experiments was approved by
the Ethical committee for animal experimentation at Gothenburg
University, Gothenburg, Sweden (approval 292-2009). The
experiments were performed in accordance with the recommen-
dations issued by the Swedish Department of Agriculture.
Rat experiments
Experiments were performed on male Sprague-Dawley rats,
weighing 240–450 g (Mo ¨llegaards Breeding Centre Ltd, Ejby,
Denmark or B&K Universal AB, Sollentuna, Sweden). The rats
were housed for at least 7 days prior to experiments in animal
quarters (22uC, 60% relative humidity, artificial lighting between
06.00 and 18.00 h). Before the experiments the rats were deprived
of food for at least 12 h. All experiments were carried out between
9.30 and 15.00.
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induced with pentobarbital (60 mg/kg body wt.) i.p. in all
experiments except those in which the intestinal segments were
chronically denervated (see below). A tracheal cannula was
inserted and a femoral vein was cannulated. Arterial pressure
was continuously monitored in a femoral artery on a Grass
polygraph. The arterial catheter was also used to maintain
anesthesia by a continuous infusion of a-chloralose (Alfa Aesar
GmbH & Co, Karlsruhe, Germany; 3 mg/ml; 20 mL/min) in a
solution containing 138 mM glucose and 33 mM NaHCO3. Body
temperature was kept around 38uC with a heated operating table.
At the end of the experiments the animals were killed by an i.v.
injection of a saturated KCl solution while still anesthetized.
A midline abdominal incision was performed. The influence of
the extrinsic autonomic nervous supply to the intestinal segments
was minimized by cutting the nerves along the superior mesenteric
artery.
Experimental procedures. Two to six 2–6 cm long jejunal
segments were isolated 5–10 cm below the ligament of Treitz. The
experiments with capsaicin were performed using two types of
preparations. In most experiments only the proximal ends of the
segments were cannulated with plastic tubing and the intestinal
segment was perfused by means of a pump at a rate of 20 mL per
min (‘‘perfusion experiments’’). In other experiments the distal
ends were also provided with plastic tubing closed by plugs (‘‘non-
perfusion experiments’’). The original capsaicin solution contained
16 mM capsaicin dissolved in a solution containing Tween 80 (1
part), ethanol (1 part) and NaCl (0.9%; 8 parts). The concentration
of capsaicin most often used (1.6 mM) was obtained by a 10 times
dilution of the 16 mM solution with physiological saline. The
control solution did not contain capsaicin. In some experiments
the intestinal mucosa was exposed to cholera toxin (List Biological
Laboratories, Campbell, California; 20 mg per mL physiological
saline) or to saline. The TK experiments (see below) lasted for
60 min, whereas the [methyl-
3H]thymidine and BrdU experi-
ments were prolonged to 120 min.
At predetermined times intestinal segments were removed.
Macroscopically apparent Peyer’s patches were removed. Intesti-
nal segments to be utilized for immunohistochemistry or
autoradiography were placed in buffered a 4% paraformaldehyde
(pH 7.0) solution. Intestinal segments to be used for estimation of
thymidine kinase or DNA were immediately frozen in liquid
nitrogen and kept at 220uCo r285uC until determination. In all
types of experiments the choice of segments was randomized.
Lidocaine experiments. In one type of experiments the
intestinal mucosa was exposed to lidocaine, a local anaesthetic,
together with capsaicin. About 10 min before exposing the
intestinal segment to capsaicin the segment was flushed with a 1%
lidocaine (w/v) in physiological saline. Furthermore, the capsaicin
solution contained 0.2% lidocaine (perfusion experiments) or 1%
lidocaine (non-perfusion experiments). Control solutions lacked
capsaicin. One may argue that tetrodotoxin, a more specific nerve
blocking agent than lidocaine, would have been more appropriate.
However, the use of tetrodotoxin in in vivo experiments is greatly
complicated by itshigh generaltoxicity fortheexperimental animal.
Neurotransmitter receptor blockade. Several neurotran-
smitter antagonists were tested. Atropine (a muscarinic receptor
blocker; 0.5 mg kg
21 b.wt.) or 8-37 a-GGRP (a CGRP receptor
blocker; 1 mg kg
21 b.wt;) was administered i.v. at times 0 and
60 min. Hexamethonium (a nicotinic receptor blocker; 10 mg
kg
21 b.wt) or Sendide (1 mg kg
21 b.wt; a NK1 receptor blocker)
was administered i.v. every 30. min.
Neurotransmitter i.a. infusions. SP or CGRP were
infused i.a. retrogradely via a catheter in the left carotid artery
at a rate of 10
29 mol per min. The peptides were dissolved in a 1%
albumin-saline solution. In the cholera toxin and neurotransmitter
experiments the intestines were not perfused.
BrdU experiments. In 5 experiments bromodeoxyuridine
(BrdU; a thymidine analogue; Roche Diagnostics Scandinavia,
Bromma, Sweden; dissolved in physiological saline; 50 mg/kg
b.wt.) was administered i.v.
Chronic denervation experiments. In 5 experiments the
intestinal segments were denervated periarterially 2–3 weeks prior
to the acute experiments. The rats were anesthetized with ketamin
(Ketalar, Pfizer Animal Health; 75 mg/kg b.wt. i.p.) and
medetomidine (Domitor vet., Orion Oyj, Espoo, Finland; a2-
adrenoreceptor agonist; 0.5 mg/kg b.wt. i.p.). The superior
mesenteric artery was dissected free about 10 mm from its origin
from the aorta. A wide portion of the tissue surrounding the artery
and containing the periarterial nerves was divided between
ligatures. To ablate any nerve fiber bundles that were not
severed by this procedure the arterial vessel was painted with a 5%
phenol solution. The abdomen was closed by ligatures and the
animals were placed in a heated cage. The animals were aroused
by giving atipamezole (Antisedan vet., Orion Oyj, Espoo, Finland;
a2-adrenoreceptor antagonist; 0.5 mg/kg b.wt. i.p.). The acute
experiments carried out later were performed as described above
(‘‘perfusion experiments’’). The success of denervation was tested
by an immunohistochemical investigation of the presence of
thyrosine hydroxylase (marker of adrenergic nerve fibers; see
below).
Determination of thymidine kinase activity. Thymidine
kinase (TK) catalyses the phosphorylation of deoxythymidine to
deoxythymidine-5-phosphate. TK activity in the intestine was
measured in duplicate samples as described [30,75,76]. Intestinal
biopsies were homogenized (Polytron PT 1200 homogeniser) in a
2 ml Eppendorf tube with a Tris-phosphate buffer (pH 7.3) at 0–
4uC and centrifuged at 16 0006g for 20 min, a g-force above that
which enriches the pellet with mitochondria [30]. Supernatant
(100 ml) was added to a reaction mixture (volume 1.275 mL)
containing ATP (12 mM), phosphoglycerate (10 mM), MgCl2
(4 mM), NaF (3 mM), thymidine (0.4 mM) and [methyl-
3H]-
thymidine (12.5 or 25 mCi corresponding to 0.2 or 0.4 mM;
Amersham Biosciences, Buckinghamshire, U.K.) in a 0.05 M
TrisHCl buffer (pH 8). After a 20 min incubation period at 37uC
in a metabolic shaker, the reaction was stopped by filtering the
solution with a small volume of NaCOOH through an ion
exchange filter (Whatman DE 81) This filter retained labelled
dTMP, whereas free thymidine was washed away. After repeated
washings with NaCOOH and water, the filter was placed in a
scintillation counting vial together with 1 ml of a solution
containing HCl (2 M) and NaCl (1 M) in a 1:1 relationship.
After 10 min scintillation fluid (Quickszint 361, Zinsser Analytical,
Frankfurt, Germany) was added. The radioactivity was measured
in a Packard 1900 TR Liquid scintillation analyser.
Thymidine incorporation into DNA. [Methyl-
3H]thy
midine (25 or 50 mCi; Amersham Biosciences) was given i.v. half
an hour after exposing an intestinal segments to cholera toxin or
just prior to perfusing intestinal segments with 1.6 mM capsaicin
or a control solution. DNA was isolated as described [77]. The
amount of DNA was estimated from measurements of absorbance
at 260 nm [78]. The radioactivity was measured in a Packard
1900 TR Liquid scintillation analyser.
Immunohistochemistry. Biopsies from the rat small in-
testine immersed in buffered 4% paraformaldehyde (pH 7.0) were
subsequently embedded in paraffin.
Bromodeoxyuridine (BrdU) is a thymidine analogue, which
can be localized in tissue with histochemical techniques. It is
Nervous Control of Stem Cells
PLoS ONE | www.plosone.org 10 February 2011 | Volume 6 | Issue 2 | e16295incorporated into the DNA during the S phase making it possible
to quantify the number of newly formed cells. In the present
experiments intestinal segments were extirpated 2 h after giving
BrdU (50 mg/kg b.wt.) i.v. The tissue was immersed in buffered
4% paraformaldehyde (pH 7.0), embedded in paraffin and cut at
4 mm. Endogenous peroxidase was inactivated with 3% H2O2.
Non-specific protein binding was blocked with 4% normal donkey
or 1.5% normal rabbit serum in Tris-buffered saline (TBS) for
30 min. The sections were exposed to monoclonal rat BrdU
antibodies (0.5 mg/ml; Adb Serotec, Oxford, UK) over night at
4uC followed by incubation with avidin-biotin-peroxidase complex
(ABC Elite, Vector laboratories, Inc., Burlingame, California) for
60 min at room temperature. The immunoreactivity was visual-
ized with 3.39-diaminobenzidine tetrahydrochloride (DAB;
0.50 mg/ml). Most biopsies were counterstained with Mayer’s
hematoxyline. As a negative tissue sections were immunostained
without exposure to the primary antibody, which did not result in
any staining of the tissue. The number of BrdU labelled crypt cells
was counted in coded tissue sections at 200 times magnification
using an Olympus BX60 microscope. The crypts had to fulfil two
criteria to be included when estimating number of BrdU labelled
cells. First, a crypt lumen was seen along the length of the crypt.
Second, the bottom of the crypt was located close to the
submucous layer.
Immunohistochemical investigation of muscarinic receptor
(mAChR) expression was in some experiments undertaken on
20 mm thick sections, which were deparaffined and re-hydrated by
heating the slides to 60uC for one hour followed by subjection to
xylene, decreasing concentrations of ethanol and TBS. The
sections were then immersed in a 10 mM citrate buffer (pH 6.0)
and microwaved for four cycles of 6 min. Endogenous peroxidase
was inactivated with 0.03% H2O2. Non-specific protein binding
was minimized with 5% bovine serum albumin (BSA) in TBS for
30 min. The sections were then incubated overnight at room
temperature in a humidified chamber with polyclonal rabbit anti-
mAChR subtype specific antibodies (Research and Diagnostic
Antibodies, Berkley, California) diluted 100 times in TBS
containing 1% BSA. The presence of the muscarinic receptor
immunoreactivity was revealed using Alexa Fluor 488 goat anti-
rabbit Ig G (Molecular Probes, Eugene, Oregon) and analyzed
using a Radiance 2000 Confocal Imaging System (Bio-Rad,
Hercules, California) and the LaserSharp 2000 software
(Bio-Rad).
Certain other sections (4 mm thick) were treated with an
immunoenzymatic method. Generally speaking, the method was
similar to that described above with two modifications: endoge-
nous peroxidase was inactivated with 0.6% H2O2 and the sections
were stained with a secondary biotinylated goat antirabbit
antibody (Dako, Sweden AB, Solna, Sweden) followed by a
horseradish peroxidase-labeled avidin-biotin complex (Dako). The
colour was then developed with AEC substrate chromogen (Dako).
The sections were analyzed with an Olympus BX60 microscope.
Control sections were immunostained without exposure to the
primary antibody. It has previously been shown that the binding of
the muscarinic receptor antibodies used in the present study are
blocked by preincubation with its specific antigen [79].
We have used the adrenergic innervation to test presence or
absence of external innervation after severing the intestinal
periarterial nerves. This method is based on the absence of
adrenergic nerves in the ENS that are confined to the intestinal
wall. Therefore, adrenergic nerves are extrinsic and their absence
in intestinal segments indicates a successful surgical denervation.
This method has been used extensively [for experiments on rats,
see references 80–82]. Tissue from every experimental segment
was immersed in buffered 4% paraformaldehyde (pH 7.0) and
embedded in paraffin. Four mm thick tissue sections were collected
at a regular distance of 40 mm between biopsies. The sections were
deparaffined in xylene and decreasing concentrations of ethanol
and then immersed in 10 mM citrate buffer (pH 6.0) at 100uC.
Endogenous peroxidise activity was blocked by 0.3% H2O2 The
sections were exposed to a mouse, monoclonal, tyrosine
hydroxylase antibody (Affinity BioReagents, AH Diagnostics,
Ska ¨rholmen, Sweden) for 45 min at room temperature. A biotin
rat anti-mouse IgG1 (BD Biosciences Sweden, Stockholm,
Sweden) was used as a secondary antibody. After exposure to a
peroxidase-conjugated avidine-biotin complex (ABC-complex,
Dako) the sections were stained with an AEC-substrate (Dako)
and counterstained with Mayer’s hematoxyline. Control sections
were immunostained without exposure to the primary antibody,
which did not result in any staining of the tissue.
Autoradiography experiments. Methyl-
3H-thymidine (50
or 100 mCi; specific activity 70–75 Ci/mmol; Amersham
Biosciences, UK) in physiological saline, was given i.v. four or
six hours prior to extirpation of the intestinal segment. After
embedding in paraffin, the biopsy was cut at 4 mm. For
autoradiography the histological sections were deparaffinated
with xylene and dehydrated with ascending concentrations of
ethanol. The sections were dipped in a photographic solution
(Ilford K2) for 10 s, exposed usually for about 4 weeks, developed
and fixed. The sections were then stained (Van Gieson). The
autoradiographs were analyzed by conventional bright field
microscopy as well as by dark field microscopy.
Mouse experiments
Experiments were performed on mice devoid of the capsaicin
receptor (TRPV1 [27]; strain B6.129X1-Trpv1) purchased from
The Jackson Laboratory (Bar Harbor, Maine). Strain B6129SF2/J
was used as controls as recommended by the distributor. The mice
were kept in animal quarters under standardized environmental
conditions (see above). At the time of the experiments the animals
were 10 weeks old.
3H-thymidin (2 mCi) or BrdU (100 mg/kg body weight)
dissolved in physiological saline was administered i.p.. Two h
later the mice were killed with an overdose of sodium
pentobarbital i.p.
3H-thymidine incorporation into DNA was
determined and BrdU labeled cells were stained and counted as
described for rat experiments.
Chemicals
Peptides were bought from Bachem AG, (Bubendorf, Switzer-
land). All other chemicals, for which any supplier has not been
indicated in text, were purchased from Sigma-Aldrich Sweden,
Stockholm, Sweden.
Recordings of heart rate
Heart rate was monitored on line with a rate meter coupled to
the blood pressure recorder sensing the arterial pressure
oscillations and recorded on a Grass polygraph.
Statistics
Non-parametric statistics were used throughout. Significance
between paired observations was determined using Wilcoxon
matched-pairs test. The Mann-Whitney U test was utilized when
comparing independent groups. All calculations were performed
with SPSS for Windows. Level of statistical significance was set at
p,0.05.
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